
ABUS vs SVRA
$ABUS vs $SVRA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ABUS vs SVRA: the quick read
- ·SVRA is the larger company by market cap ($994M vs $821M).
- ·ABUS has been more active on our scanner (111 vs 79 alerts in 30 days).
- ·SVRA has the smaller float (152.5M vs 181.8M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 111 and 79 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 21% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: SVRA is outperforming the other by roughly 8.4 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ABUS and SVRA on TheDesperateTrader.
- Is ABUS or SVRA the better stock?
- "Better" depends on your goal, and these two are not alike. SVRA is the larger company by market cap ($994M vs $821M). ABUS has been more active on our scanner (111 vs 79 alerts in 30 days). SVRA has the smaller float (152.5M vs 181.8M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ABUS and SVRA?
- The differences that matter: they are not in the same business - ABUS is pharmaceutical preparations and SVRA is pharmaceutical preparations; they are similar in size ($821M vs $994M); they trade at very different share prices ($4.11 vs $5.20); ABUS sits at 31% of its 52-week range against 51% for SVRA; our scanner flagged ABUS 111 times in the last 30 days against 79 for SVRA. Everything above is measured from the latest completed session and SEC filings.
- Which of ABUS and SVRA is more active right now?
- Right now ABUS is at about 0.3x its normal volume and SVRA is at about 0.6x, so SVRA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ABUS or SVRA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ABUS and SVRA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.